Dabur India updated the KMPs authorised to determine materiality under Regulation 30(5), effective 14 November 2026. It covers contact details and authorisations only, with no business event.
Jagran Prakashan issued a press release on Q2FY27 unaudited results, reporting consolidated revenue of Rs 493.44 crore and PAT of Rs 42.82 crore. Profit declined year-on-year versus Rs 56.94 crore.
Amwill Health Care signed an exclusive private-label supply agreement with a Thai pharma manufacturer. The five-year deal covers hair colour imports for India, with no upfront payment.
Saroja Pharma's statutory auditor, Pravin Chandak & Associates, revised its resignation to be effective 15 November 2026. The auditor cites pre-occupation in other professional assignments as the reason.
Deccan Gold reported Q2 FY27 standalone net profit of Rs.6.51 Crore on rising Swarnagiri gold output. Associate profit share more than doubled, narrowing the consolidated loss.
Promoters Ruchika Bhojwani and T.W. Bhojwani Leasing bought 295 Bright Brothers shares via market purchase on 5 and 12 November 2026. Combined consideration was about Rs.0.0064 Crore.
Dhanvantri Jeevan Rekha reported Rs 857 lakh quarterly net sales and Rs 14 lakh profit. Figures are unaudited and were approved by the board on November 13, 2026.
DCW bought back 87,226 equity shares on November 13, 2026, at an average price of Rs 47.70 through the open market. Cumulative shares bought back now total 11,92,684.
Wipro granted 2,66,203 ADS Restricted Stock Units under its 2024 ESOP/PSU/RSU scheme to employees of the company and subsidiary. Grant effective November 13, 2026; vesting per committee schedule.
Crimson Metal Engineering's board approved unaudited standalone results for the quarter ended 30 September 2026. The results report quarterly revenue from operations and profit.
Ashram Online.com approved unaudited standalone results for the quarter and half year ended September 30, 2026. A limited review report from Darpan & Associates is enclosed.
Starbeam Ventures postponed its board meeting from 13 November 2026 to 18 November 2026 to consider Q2 and half-year results. The delay in finalising the financial results prompted the rescheduling.
Impera Worldwide approved unaudited Q2 FY27 results on November 13, 2026, with a limited review report. The quarter shows a Rs. 2.17 lakh net profit, with no revenue from operations.
TechNVision Ventures Ltd's board approved unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The outcome letter itself carries no revenue or profit figures.
Exim Routes filed CARE Ratings' IPO proceeds monitoring report for quarter ended September 2026. It reports nil deviation from objects but flags vendor changes and fund interchanges.